CANESPOR

This brand name is authorized in Finland, Croatia, Ireland, Poland, Romania, South Africa

Active ingredients

The drug CANESPOR contains one active pharmaceutical ingredient (API):

1 Bifonazole UNII QYJ305Z91O - BIFONAZOLE

Bifonazole is an imidazole derivative with a broad antimycotic spectrum, which includes dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur. It is also effective against Corynebacterium minutissimum. Read about Bifonazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CANESPOR Cream	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AC10	Bifonazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 570210
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-662982508
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100045005, 100349700, 100350665, 100364615, 100366206, 100434770
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W55195002, W55196002, W55196003
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/13.9.2/203, R/13.9.2/204